Neuroprotection in Patients Undergoing Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 383 participants.
Also called NCT02389894
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 383 participants
- Registry
-
NCT02389894
-
- Other papers using this trial's data
- Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial
- The impact of perioperative stroke and delirium on outcomes after surgical aortic valve replacement
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02389894. Randomized; single masking; primary purpose prevention. Start 2015-03 (registry gives no type); primary completion 2017-01 (actual). Results posted on 2019-04-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neuroprotection in Patients Undergoing Aortic Valve Replacement
- Condition
- Aortic Stenosis
- Condition
- Brain Infarction
- Condition
- Cerebrovascular Accident
- Condition
- Stroke
- Intervention (Device)
- Embol-X Embolic Protection Device
- Intervention (Device)
- CardioGard Cannula
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct02389894- Content hash
3b1c558fa4ba553569f0b47f6f4f5f576fb24f6b4379a3ffaac167d5d7638aa4